Myriad Genetics | MYGN - Market Capitalization

Stock Price
4.78
Daily Change
-0.01 -0.21%
Monthly
2.14%
Yearly
-35.58%
Q2 Forecast
4.68

Myriad Genetics reported $430.5M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Bio-Rad Laboratories USD 8.21B 601M Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Danaher USD 140.45B 11.98B Apr/2026
Illumina USD 20.62B 6.53B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Mettler Toledo International USD 28.48B 3.19B Dec/2025
Myriad Genetics USD 575M 98M Dec/2025
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 22.89B 1.19B Apr/2026
Quidel USD 1.99B 66M Dec/2025
Repligen USD 9.22B 1.7B Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Standard Biotools USD 492M 5M Dec/2025
Thermo Fisher Scientific USD 177.96B 4.7B Apr/2026
Veracyte USD 3.33B 627M Dec/2025
Waters USD 22.61B 5.25B Dec/2025